The Marcus Center for Cellular Therapy welcomes Dr Helen Heslop to Emory as she presents her seminar entitled: "Extending Applicability of CAR-T cells"

Dr. Helen Heslop is Dan L Duncan Chair, Professor of Medicine and Pediatrics and Director of the Center for Cell and Gene Therapy at Baylor College of Medicine, Houston Methodist Hospital and Texas Children’s Hospital.  Additionally, she holds the role of. the Deputy Director of the Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine

Dr Heslop is a physician scientist engaged in translational research focusing on adoptive immunotherapy with gene-modified effector cells, to improve hemopoietic stem cell transplantation and cancer therapy. An additional focus in reconstituting antiviral immunity post transplant. She therefore has extensive experience in developing and conducting transplant studies and cell and gene therapy studies and currently holds over 20 INDs.

She serves as Principal Investigator on several peer-reviewed research programs, including an NCI-funded SPORE in lymphoma and the Meg Vosberg Stand Up to Cancer Dream Team in T cell lymphoma. She is also the principal investigator on an NHLBI-funded training grant in Cell and Gene Therapy. She is a past President of the American Society for Gene and Cell Therapy (ASGCT), the American Society of Blood and Marrow Transplant (ASBMT) and the Foundation for Accreditation of Cell Therapy (FACT) and the past chair of the BMT CTN Steering Committee. She is an elected member of the American Association of Physicians and the National Academy of Medicine